The coronavirus disease 2019 (COVID-19) pandemic has been a major global focus since 2019. However, drug development and vaccination have been unable to stop the rise in the number of COVID-19 infections. As a result, almost everyone has been infected with COVID-19. As the COVID-19 pandemic nears its end, it is important to explore whether contracting COVID-19 has any irreversible effects on the female reproductive system. This article aims to review the effects of COVID-19 on the female ovary and reproductive system and examine whether these effects are permanent. In conclusion, we can state that COVID-19 has not caused any long-lasting effects on the reproductive health of most women, with the exception of a few cases where premature ovarian failure has been observed. These temporary effects, such as menstrual disturbances and temporary fertility loss, tend to diminish and eventually disappear over time.
27 December 2024 in Journal of Assisted Reproduction and Genetics
Purpose In China, the prevalence of hepatitis B virus (HBV) infection among infertile couples is a significant clinical problem. It is necessary to determine the effect of HBV infection on embryo development. Methods The 4301 fresh cycles and 5763 frozen embryo transfer (FET) cycles were grouped according to the couple with or without HBV infection. The embryo fertilization rate, cleavage rate, transplantable embryo rate, and rate of high-quality embryos were analysed. The methylation status of maternal antigen that embryos require (MATER), zygote arrest 1 (ZAR1) and growth differentiation factor 9 (GDF9) genes in the peripheral blood of assisted reproductive technology (ART) women was detected by methylation-specific polymerase chain reaction (MSP). Results The pregnancy rate of the female HBV-positive group was significantly lower than that of the HBV-negative group. The fertilization rate of intracytoplasmic sperm injection (ICSI) cycles in the male HBV-positive group was significantly lower than that of the male HBV-negative group. There were no differences in biochemistry or clinical pregnancy rates among the FET groups. The promoter methylation of GDF9 in HBV-positive ART women was higher than that in HBV-negative ART women, and that of ZAR1 in HBV-positive ART women was lower than that in HBV-negative ART women. Conclusion It was a detrimental effect of HBV infection on in vitro fertilization (IVF) and ICSI treatment outcomes in women. The HBV infection was associated with the maternal genes promoting methylation.
Epstein-Barr virus (EBV), a prevalent and virulent human γ-herpesvirus, is etiologically linked to an extensive spectrum of malignancies and autoimmune disorders. The NLR family pyrin domain-containing 3 (NLRP3) inflammasome serves as a central sensor of innate immune defense and critically modulates host-EBV crosstalk. Nonetheless, current studies mostly concentrate on individual regulatory events or specific hematological malignancies. A systematic and holistic depiction of the full bidirectional regulatory network between EBV and the NLRP3 inflammasome remains lacking. In addition, contradictory findings across different experimental models and the inherent drawbacks of existing research systems have not been objectively interpreted, which hinders a thorough understanding of this regulatory axis. Therefore, we systematically summarize the dual regulatory molecular pathways between EBV and the NLRP3 inflammasome, integrate the latest cellular and molecular mechanisms reported in recent years, critically discuss prevailing controversies and limitations in relevant research, and further explore the translational potential of NLRP3 as a therapeutic target. This review intends to refine the theoretical framework of EBV-driven tumorigenesis and immune dysfunction, and offer novel insights for future mechanistic investigations and clinical targeted therapy.